Blood products: A significant risk factor for long-term catheter-related bloodstream infections in cancer patients

Infection Control and Hospital Epidemiology

Volumn 22, Issue 3, 2001, Pages 165-166

  Hanna, H A ^a   Raad, I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INTRAVENOUS ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THROMBOCYTOPENIA; VEIN CATHETERIZATION;

EID: 0035079684     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501885     Document Type: Article

References (7)

1. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion
2. Guideline for prevention of intravascular device-related infections
3. Risk factors for infection of adult patients with cancer who have tunneled central venous catheters
4. Infectious morbidity associated with long-term use of venous access devices in patients with cancer
5. Low infection rate and long durability of nontunneled silastic catheters: A safe and cost-effective alternative for long-term venous access
6. Adhesion of Staphylococcus aureus to surface-bound platelets: Role of fibrinogen/fibrin and platelet integrins
7. Minocycline and ethylenediamine-tetraacetate for the prevention of recurrent vascular catheter infections